InMode Ltd vs Snap Inc — how do they compare? InMode Ltd trades at $14.07 (market cap $806.05M), while Snap Inc trades at $5.89 (market cap $9.83B). The key difference: Snap Inc is far larger — about 12.2× InMode Ltd's market cap, and InMode Ltd is more actively traded (511,446 versus 28,532,342). Which is the better fit depends on your goals — on Pluang, investors hold InMode Ltd for 29 Days and Snap Inc for 68 Days on average.
| INMD | SNAP | |
|---|---|---|
Market Cap | $806.05M | $9.83B |
Volume | 511,446 | 28,532,342 |
Sector | Health | Media |
52-Week High | $16.62 | $9.09 |
52-Week Low | $12.76 | $3.93 |
Typical Hold Time | 29 Days | 68 Days |
Enterprise Value | $309.39M | $11.39B |
Signals from Pluang's Aura AI — not financial advice
INMD trades at $14.01, showing minimal daily movement with a 0.14% gain. The stock faces bearish technical signals despite attractive valuation metrics including a P/E of 11.58 and EV/EBITDA of 4.43. Recent earnings show mixed results with Q2 2026 beating expectations but Q1 2026 missing, while the company faces shareholder activism from Steel Partners' $16.75 per share acquisition offer. Revenue guidance for 2026 remains stable at $365M-$375M.
The investment case balances strong profitability margins against technical weakness and activist pressure. With 45% analyst buy ratings and no sell recommendations, fundamental value appears intact, but near-term price action suggests caution. Key catalysts include Q3 2026 earnings and resolution of the acquisition proposal, while risks include execution challenges and macroeconomic headwinds affecting aesthetic medicine demand.
Snap Inc. (SNAP) trades at $5.865, up 1.12% with a bullish technical signal. Revenue grew to $5.93B in 2025, though net losses persist at -$460M. Recent news highlights AI integration in SPECS glasses via partnerships with NVIDIA and Salesforce. Analyst consensus is mixed with 38% buy ratings and a $7.78 price target.
Outlook: Potential upside exists from AI initiatives and revenue growth, but profitability challenges and high debt ($3.61B) pose risks. The stock's valuation (P/S 1.55) appears reasonable, yet investor caution is warranted amid regulatory pressures and competitive threats.
Trailing returns across standard periods
Latest headlines on both assets
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.
Read more on SNAP →